Skip to content

FP7H2020HORIZON

Karolinska Institutet

Country
SESweden
Defence projects
0
Projects, all programmes
705
As coordinator
254
EU contribution (CORDIS)
EUR 463,574,152
Active
2008 to 2026

Projects

705 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
CoroNAbNanobodies and antibodies against 2019-nCoVH20202020CoordinatorEUR 1,816,859
EPHORExposome project for health and occupational researchH20202020ParticipantEUR 791,445
TERMINETnexT gEneRation sMart INterconnectEd ioTH20202020ParticipantEUR 199,688
AND-PDCOMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASEH20202020ParticipantEUR 1,058,868
RESCUERRESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.H20202020ParticipantEUR 424,781
SYNKITSynthetic Natural Killer Cells for ImmunotherapyH20202020CoordinatorEUR 191,852
BRAINTIMEMolecular atlas of the brain across the human lifespanH20202020CoordinatorEUR 1,198,069
COVID-XCOVID eXponential ProgrammeH20202020ParticipantEUR 414,250
GUT-SEQSingle-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel diseaseH20202020CoordinatorEUR 1,500,000
MITafterVITUnravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseasesH20202020CoordinatorEUR 191,852
RISCCRISK-BASED SCREENING FOR CERVICAL CANCERH20202020ParticipantEUR 855,480
TroyCANRedefining the esophageal stem cell niche – towards targeting of squamous cell carcinomaH20202020CoordinatorEUR 1,483,389
H-WORKMULTILEVEL INTERVENTIONS TO PROMOTE MENTAL HEALTH IN SMEs AND PUBLIC WORKPLACESH20202020ParticipantEUR 145,625
AFFECT-EUDIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITYH20202020ParticipantEUR 0
PHOTO-IASISNanoengineered coatings for visible-light photocatalytic disinfection of medical devicesH20202020CoordinatorEUR 191,852
HS-SEQHEPARIN AND HEPARAN SULPHATE: FROM SEQUENCE DETERMINATION TO THERAPEUTIC STRATEGIES FOR PARKINSON’S DISEASEH20202020ParticipantEUR 717,500
MacinNASHRevealing the contribution of liver macrophage populations to NASH in insulin resistanceH20202020CoordinatorEUR 1,999,781
KILL-OR-DIFFERENTIATUsing cell-cell interactions to unlock new cancer treatments: Forcing neural crest tumors back onto the developmental pathH20202020ParticipantEUR 3,284,680
IMaPImaging tumor vessels as a marker for p53 mutation status in cancerH20202020CoordinatorEUR 203,852
ATACAntibody therapy against coronavirus (COVID-19)H20202020CoordinatorEUR 849,143

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.